The Immune System’s Role in Neurodegenerative Disease

Researchers have discovered a new connection between Parkinson’s disease development and the immune system.

The Immune System’s Role in Neurodegenerative Disease

Image Credit: McGill University

Researchers at McGill University’s The Neuro (Montreal Neurological Institute-Hospital) have found that an immune response significantly influences the formation of hazardous protein clumps, or Lewy bodies, in brain cells and their role in disease.

This implies that immune-system-triggering factors, such as long-term stress, exposure to toxins, or chronic inflammation, may be associated with the onset of Parkinson’s disease.

Our findings suggest anyone can develop Parkinson’s if exposed to the right environment, and so a genetic predisposition to disease may not be necessary. This marks a significant step forward to understanding key aspects of Parkinson’s and other neurological diseases.”

Peter McPherson, Study Senior Author and Distinguished James McGill Professor, McGill University

His group collaborated with the Early Drug Discovery Unit at The Neuro.

He added that the results, published in Nature Neuroscience, provide new opportunities for treatments designed to control immune responses.

Recreating a Hallmark of Parkinson's Disease

For the first time, researchers replicated Lewy bodies in real human neurons produced from stem cells. The researchers observed the formation of protein clusters in real time and determined the necessary conditions: the presence of α-synuclein and an immune response. Lewy bodies are generated solely in dopamine-producing neurons, the brain cells afflicted in Parkinson's disease, not in other neurons.

Until now, Lewy bodies in human neurons could only be investigated after death, which limited researchers’ understanding of them.

The researchers also revealed that Lewy bodies comprise more than misfolded proteins, as previously thought. This enhanced understanding of their composition, combined with the ability to examine their production in real-time, could give drug developers new targets for slowing the progression of Parkinson’s disease, which has no treatment and affects over 100,000 Canadians.

More Evidence of the Immune System’s Important Role

The results support previous research showing that an immune response plays an important role in Parkinson’s development. Future studies should focus on understanding how inflammation caused by an overexcited immune system causes Lewy body formation when coupled with α-synuclein.”

Armin Bayati, Study First Author and PhD Candidate, McGill University

Source:
Journal reference:

Bayati, A., et al. (2024) Modeling Parkinson’s disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines. Nature Neuroscience. doi.org/10.1038/s41593-024-01775-4.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Research Challenges Views on Human Brain Evolution